Switching Human Immunodeficiency Virus Therapy : Basic Principles and Options - 06/08/24
Doi : 10.1016/j.idc.2024.04.002
Danilo Bacic Lima, MD a, b 
, Daniel A. Solomon, MD b, c, ⁎
, Daniel A. Solomon, MD b, c, ⁎ a Massachusetts General Hospital and Brigham & Women’s Hospital
b Infectious Diseases Division, Brigham and Women’s Hospital, 75 Francis Street, PBB-A4, Boston, MA 02115, USA
c Harvard Medical School
∗Corresponding author. Infectious Diseases Division, Brigham and Women’s Hospital, 75 Francis Street, PBB-A4, Boston, MA 02115.Infectious Diseases DivisionBrigham and Women’s Hospital75 Francis Street, PBB-A4BostonMA02115
Résumé |
The number of options for effective antiretroviral therapy (ART) is steadily increasing. Although older regimens may achieve the goal of virologic suppression, newer options can offer advantages in safety, tolerability, and convenience. In this article, we offer guiding principles for switching ART, highlighting reasons to pursue a switch and key factors to consider when selecting a new regimen.
Le texte complet de cet article est disponible en PDF.Keywords : HIV, ART, Switch, Antiretroviral
Plan
© 2024
Elsevier Inc. Tous droits réservés.
Vol 38 - N° 3
P. 409-422 - septembre 2024 Retour au numéro
Article précédent
- The Current Pipeline of Antiretroviral Therapy : Expanding Options and Filling Gaps
- Yijia Li, Madhu Choudhary, John W. Mellors
- Advances in HIV Management During Pregnancy and Infant Feeding
- Mariana Espinal, Lynn M. Yee, Stephanie A. Fisher
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?